AIM: In an effort to identify patients with uveal melanoma at high risk of metastasis, the authors undertook correlation of gene expression profiles with histopathology data and tumour-related mortality. METHODS: The RNA was isolated from 27 samples of uveal melanoma from patients who had consented to undergo enucleation, and transcripts profiled using a cDNA array comprised of sequence-verified cDNA clones representing approximately 4000 genes implicated in cancer development. Two multivariate data mining techniques--hierarchical cluster analysis and multidimensional scaling--were used to investigate the grouping structure in the gene expression data. Cluster analysis was performed with a subset of 10,000 randomly selected genes and the cumulative contribution of all the genes in making the correct grouping was recorded. RESULTS: Hierarchical cluster analysis and multidimensional scaling revealed two distinct classes. When correlated with the data on metastasis, the two molecular classes corresponded very well to the survival data for the 27 patients. Thirty two discrete genes (corresponding to 44 probe sets) that correctly defined the molecular classes were selected. A single gene (ectonucleotide pyrophosphatase/phosphodiesterase 2; autotaxin) could classify the molecular types. The expression pattern was confirmed using real-time quantitative PCR. CONCLUSIONS: Gene expression profiling identifies two distinct prognostic classes of uveal melanoma. Underexpression of autotaxin in class 2 uveal melanoma with a poor prognosis needs to be explored further.
AIM: In an effort to identify patients with uveal melanoma at high risk of metastasis, the authors undertook correlation of gene expression profiles with histopathology data and tumour-related mortality. METHODS: The RNA was isolated from 27 samples of uveal melanoma from patients who had consented to undergo enucleation, and transcripts profiled using a cDNA array comprised of sequence-verified cDNA clones representing approximately 4000 genes implicated in cancer development. Two multivariate data mining techniques--hierarchical cluster analysis and multidimensional scaling--were used to investigate the grouping structure in the gene expression data. Cluster analysis was performed with a subset of 10,000 randomly selected genes and the cumulative contribution of all the genes in making the correct grouping was recorded. RESULTS: Hierarchical cluster analysis and multidimensional scaling revealed two distinct classes. When correlated with the data on metastasis, the two molecular classes corresponded very well to the survival data for the 27 patients. Thirty two discrete genes (corresponding to 44 probe sets) that correctly defined the molecular classes were selected. A single gene (ectonucleotide pyrophosphatase/phosphodiesterase 2; autotaxin) could classify the molecular types. The expression pattern was confirmed using real-time quantitative PCR. CONCLUSIONS: Gene expression profiling identifies two distinct prognostic classes of uveal melanoma. Underexpression of autotaxin in class 2 uveal melanoma with a poor prognosis needs to be explored further.
Authors: K Sisley; I G Rennie; M A Parsons; R Jacques; D W Hammond; S M Bell; A M Potter; R C Rees Journal: Genes Chromosomes Cancer Date: 1997-05 Impact factor: 5.006
Authors: A D Singh; L Boghosian-Sell; K K Wary; C L Shields; P De Potter; L A Donoso; J A Shields; L A Cannizzaro Journal: Cancer Genet Cytogenet Date: 1994-02
Authors: R Folberg; J Pe'er; L M Gruman; R F Woolson; G Jeng; P R Montague; T O Moninger; H Yi; K C Moore Journal: Hum Pathol Date: 1992-11 Impact factor: 3.466
Authors: M L Stracke; H C Krutzsch; E J Unsworth; A Arestad; V Cioce; E Schiffmann; L A Liotta Journal: J Biol Chem Date: 1992-02-05 Impact factor: 5.157
Authors: R Folberg; V Rummelt; R Parys-Van Ginderdeuren; T Hwang; R F Woolson; J Pe'er; L M Gruman Journal: Ophthalmology Date: 1993-09 Impact factor: 12.079
Authors: Mandi M Murph; Guowei W Jiang; Molly K Altman; Wei Jia; Duy T Nguyen; Jada M Fambrough; William J Hardman; Ha T Nguyen; Sterling K Tran; Ali A Alshamrani; Damian Madan; Jianxing Zhang; Glenn D Prestwich Journal: Bioorg Med Chem Date: 2015-07-02 Impact factor: 3.641
Authors: J William Harbour; Manuel Paez-Escamilla; Louis Cai; Scott D Walter; James J Augsburger; Zelia M Correa Journal: Am J Ophthalmol Date: 2018-09-07 Impact factor: 5.258
Authors: Matthew G Field; Jeffim N Kuznetsov; Parker L Bussies; Louie Z Cai; Karam A Alawa; Christina L Decatur; Stefan Kurtenbach; J William Harbour Journal: Clin Cancer Res Date: 2019-07-08 Impact factor: 12.531
Authors: Michael D Onken; Lori A Worley; Devron H Char; James J Augsburger; Zelia M Correa; Eric Nudleman; Thomas M Aaberg; Michael M Altaweel; David S Bardenstein; Paul T Finger; Brenda L Gallie; George J Harocopos; Peter G Hovland; Hugh D McGowan; Tatyana Milman; Prithvi Mruthyunjaya; E Rand Simpson; Morton E Smith; David J Wilson; William J Wirostko; J William Harbour Journal: Ophthalmology Date: 2012-04-21 Impact factor: 12.079
Authors: Christina L Decatur; Erin Ong; Nisha Garg; Hima Anbunathan; Anne M Bowcock; Matthew G Field; J William Harbour Journal: JAMA Ophthalmol Date: 2016-07-01 Impact factor: 7.389
Authors: Scott D Walter; Daniel L Chao; William Feuer; Joyce Schiffman; Devron H Char; J William Harbour Journal: JAMA Ophthalmol Date: 2016-07-01 Impact factor: 7.389
Authors: Sebastian Di Cesare; Andre Nantel; Jean-Claude Marshall; Bruno F Fernandes; Emilia Antecka; Maria E Orellana; Daniel Abourbih; Antonia M Saornil; Miguel N Burnier Journal: J Cancer Res Clin Oncol Date: 2009-10-13 Impact factor: 4.553